# A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease

Study · id `cardio:ct-nct01305824` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01305824](<https://clinicaltrials.gov/study/NCT01305824>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01305824

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.

## Technical summary

Registry record NCT01305824. Randomized; quadruple masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2012-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 151 participants (enrolled count; ClinicalTrials.gov record NCT01305824, source copy `cardio:ctgov-nct01305824-2015-04-30`, retrieved 2026-10-26)
- Start date: 2011-03 (registry gives no type) (ClinicalTrials.gov record NCT01305824, source copy `cardio:ctgov-nct01305824-2015-04-30`, retrieved 2026-10-26)
- Primary completion: 2012-11 (actual) (ClinicalTrials.gov record NCT01305824, source copy `cardio:ctgov-nct01305824-2015-04-30`, retrieved 2026-10-26)
- Completion: 2012-11 (actual) (ClinicalTrials.gov record NCT01305824, source copy `cardio:ctgov-nct01305824-2015-04-30`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01305824, source copy `cardio:ctgov-nct01305824-2015-04-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01305824-2015-04-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
- Condition: Chronic Kidney Disease
- Intervention (Drug): PRT-201
- Intervention (Drug): Placebo
- Intervention (Drug): PRT-201
- Lead sponsor: Proteon Therapeutics
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Proteon Therapeutics (`cardio:org-proteon-therapeutics`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease (`cardio:pubmed-24684771`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a4533f384607e4873672aafa769533ffda5523c9a46415cf080df3a1fe50603b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
